Cardium Appoints CMO to Lead Generx™ Development Program
News Jan 24, 2006
Cardium Therapeutics, Inc. has announced the appointment of Randall W. Moreadith, M.D., Ph.D. as Executive Vice President and Chief Medical Officer.
"We are very pleased to welcome Dr. Randall Moreadith to Cardium's executive management team," said Christopher J. Reinhard, Chairman and Chief Executive Officer of Cardium Therapeutics.
"He assumes a key leadership position in our company to accelerate the late-stage clinical development of our lead product candidate, Generx, and to seek out promising corporate development opportunities."
Dr. Moreadith added, "I am very excited about joining Cardium's talented team and look forward to contributing to its future growth and success."
Before joining Cardium, Dr. Moreadith served as Chief Medical Officer of Renovis, Inc. Previously, he was co-founder, President and Chief Operating Officer of ThromboGenics Ltd., and served as Principal Medical Officer of Quintiles, Inc. where he co-founded Quintiles' Cardiovascular Therapeutics Group.
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
Faulty Gene Leads to Alcohol-Induced Heart FailureNews
A faulty gene interacts with alcohol to accelerate heart failure in susceptible patients, a study suggests. This dangerous interaction can occur even when only moderate amounts of alcohol have been consumed.READ MORE